MoneyWorks4Me

Beryl Drugs - Quaterly Results

11 Feb 2022 Evaluate
A decent increase of about 53.51% in the turnover to Rs. 32.19 millions was observed for the quarter ended December 2021. The turnover stood at Rs. 20.97 millions during the similar quarter previous year.The Net Loss for the quarter ended December 2021 is Rs. -1.02 millions as compared to Net Loss of Rs. -1.70 millions of corresponding quarter ended December 2020The company reported a good operating profit of 2.45 millions compared to 1.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 32.19 20.97 53.51 112.09 86.01 30.32 142.80 130.48 9.44
Other Income 0.00 0.00 0.00 0.39 0.05 680.00 0.00 0.00 0.00
PBIDT 2.45 1.70 44.12 8.61 13.95 -38.28 16.36 11.38 43.76
Interest 1.15 0.93 23.66 3.36 3.25 3.38 4.66 3.21 45.17
PBDT 1.30 0.77 68.83 5.25 10.70 -50.93 16.22 8.17 98.53
Depreciation 2.72 3.46 -21.39 8.16 10.38 -21.39 12.73 6.59 93.17
PBT -1.42 -2.69 -47.21 -2.91 0.32 -1009.38 3.49 1.58 120.89
TAX -0.40 -0.99 -59.60 -1.07 -0.90 18.89 1.08 1.09 -0.92
Deferred Tax -0.40 -0.99 -59.60 -1.07 -1.36 -21.32 1.08 1.46 -26.03
PAT -1.02 -1.70 -40.00 -1.84 1.22 -250.82 2.41 0.49 391.84
Equity 50.72 50.72 0.00 50.72 50.72 0.00 50.72 50.72 0.00
PBIDTM(%) 7.61 8.11 -6.11 7.68 16.22 -52.64 11.46 8.72 31.36
Peers
Company Name CMP
Sun Pharma. Inds. 1847.00
Dr. Reddys Labs. 1212.30
Cipla 1368.65
Lupin 2121.05
Zydus Lifesciences 1170.00
View more..